viraldrug-testubeFinding cures and improving global health is the focus of a wide range of biotech companies in Washington State. Seattle-based Kineta has just received a contract with the National Institutes of Health to develop immunotherapy for several viral diseases such as flu and ebola.

From establishing the first hospital in the Northwest Territories to invention of the kidney dialysis machine to the development of a Smartphone ultrasound diagnostic tool, Washington State has a long history of innovation in health care. Today, there are over 480 life sciences and global health organizations working hand-in-hand with Washington’s top-tier educational-research institutions allowing the best and brightest ideas to rise quickly to the top and reach the marketplace.

Read more in the Puget Sound Business Journal and Geekwire.

Translate »